References
- Furman R. H. Are gonadal hormones (estrogens and androgens) of significance in the development of ischemic heart disease?. Ann NY Acad Sci 1968; 149: 822
- Gordon T., Castelli W. P., Hjortland M. C., Kannel W. B. The prediction of coronary heart disease by high-density and other lipoproteins; and historical perspective. Hyperlipidemia, B. M. Rifkind, R. I. Levy. Grune and Stratton, New York 1977; 71
- Larsson-Cohn U., Berlin R., Vikrot O. Effects of combined and low dose gestagen oral contraceptives on plasma lipids including individual phospholipids. Acta Endocrinol (Kbh) 1970; 63: 717
- Larsson-Cohn U., Wallentin L., Zador G. Plasma lipids and high density lipoproteins during oral contraception with different combinations of ethinylestradiol and levonorgestrel. Horm Metab Res 1979; 11: 437
- Larsson-Cohn U., Fåhraeus L., Wallentin L., Zador G. Lipoprotein changes may be minimized by proper composition of a combined oral contraceptive. Fertil Steril 1981; 35: 172
- Steinberg D. The rediscovery of high density lipoprotein; a negative risk factor in atherosclerosis. Eur J Clin Invest 1978; 8: 107